Jim Simons
FTH icon

Jim Simons’s Faeth Therapeutics FTH Stock Holding History

Jim Simons’s Portfolio FTH Stock Details FTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$510K Sell
20,416
-11,625
-36% -$269K ﹤0.01% 2605
2026
Q1 		$1.01M Buy
32,041
+20,525
+178% +$410K ﹤0.01% 2274
2025
Q4 		$123K Buy
11,516
+1,100
+11% +$10.6K ﹤0.01% 2975
2025
Q3 		$98.4K Buy
+10,416
New +$86.4K ﹤0.01% 3253
2025
Q2 		– Sell
-8,865
Closed -$69.9K – 3872
2025
Q1 		$69.9K Buy
8,865
+1,025
+13% +$9.7K ﹤0.01% 3242
2024
Q4 		$76.8K Sell
7,840
-2,939
-27% -$29.5K ﹤0.01% 3322
2024
Q3 		$129K Sell
10,779
-410
-4% -$5K ﹤0.01% 3214
2024
Q2 		$139K Buy
11,189
+639
+6% +$13.3K ﹤0.01% 3121
2024
Q1 		$222K Buy
10,550
+3,375
+47% +$58.2K ﹤0.01% 3193
2023
Q4 		$99K Buy
7,175
+2,985
+71% +$40.7K ﹤0.01% 3302
2023
Q3 		$67K Sell
4,190
-285
-6% -$6.12K ﹤0.01% 3338
2023
Q2 		$102K Sell
4,475
-1,785
-29% -$52.3K ﹤0.01% 3465
2023
Q1 		$188K Sell
6,260
-2,368
-27% -$70.2K ﹤0.01% 3299
2022
Q4 		$257K Sell
8,628
-1,662
-16% -$48.9K ﹤0.01% 3304
2022
Q3 		$319K Sell
10,290
-2,060
-17% -$81K ﹤0.01% 3184
2022
Q2 		$561K Buy
12,350
+8,190
+197% +$307K ﹤0.01% 3097
2022
Q1 		$192K Buy
+4,160
New +$331K ﹤0.01% 3661

Other funds holding FTH

Suvretta Capital Management
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Avoro Capital Advisors
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Fairmount Funds Management
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Logos Global Management
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vivo Capital
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Caligan Partners
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return

Jim Simons's FTH Position: Q2 2026 in Review

Jim Simons reduced its Faeth Therapeutics (FTH) stake by 36% in Q2 2026, selling an estimated $269K and leaving 20,416 shares worth $510K. The position accounts for ﹤0.01% of the portfolio, ranked #2605.

Jim Simons first reported a position in FTH in Q1 2022 and has held it in 17 quarters since. The position peaked at $1.01M in Q1 2026. 45 funds tracked by Wall St. Rank hold FTH as of Q2 2026.

  • Jim Simons held 20,416 shares of Faeth Therapeutics worth $510K as of Q2 2026.
  • Jim Simons sold 11,625 Faeth Therapeutics shares in Q2 2026, an estimated $269K.
  • Faeth Therapeutics made up ﹤0.01% of Jim Simons's portfolio in Q2 2026, its #2605 holding.
  • Jim Simons first reported a position in Faeth Therapeutics in Q1 2022 and has held it in 17 quarters since.
  • Jim Simons's Faeth Therapeutics position peaked at $1.01M in Q1 2026.
  • 45 funds tracked by Wall St. Rank held Faeth Therapeutics as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.